MimiCeciliaLeeMDPhD(She/Her)

Founder and Principal, Opus 132 Strategies

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

California Institute of Integral StudiesCertificate, Psychedelic Assisted Therapies, 2023 - 2024
Columbia UniversityCertificate, Bioethics, 2018 - 2023
University of California (San Francisco)Residency, Anesthesiology, 2001 - 2004
Washington University/B-JH/SLCH ConsortiumResidency, Neurological Surgery, 1999 - 2000
Washington University/B-JH/SLCH ConsortiumInternship, Surgery, 1998 - 1999
Albert Einstein College of MedicineClass of 1998
Harvard UniversityAB, East Asian Languages and Civilizations, Cum Laude i

EVP, SamsungStrategic planning of a Gene Therapies R&D Business Unit2021 - 2022
VP, Novartis Institute of Biomedical ResearchGlobal Program Head for Gene Therapy assets for neurodegenerative diseases, Freidrich's Ataxia and Amyotrophic Lateral Sclerosis (SOD-1)2020 - 2022
Medical Director, Global Blood TherapeuticsClinical Development Lead for early development of an asset for Sickle Cell Diseases.2019 - 2020
Global Medical Lead, BioMarinLed global strategies for market engagement, evaluation and preparation in parallel with research and development for a gene therapy for Hemophilia A (ROCTAVIAN)/2016 - 2019
KOL, SonoSiteAs Co-Founder and Co-Director of Regional Anesthesia at UCSF, provided Consultant services in design and planning for interative next-generation portable ultrasound machines.2004 - 2009

Does It Hurt Now?https://youtu.be/jKFxnamQeAs
Eggsperience | Fertility Journeyhttps://youtu.be/vB0DRmgKMs0
NYTimes | Faces of Breast Cancerhttps://www.nytimes.com/interactive/projects/well/breast-cancer-stories/stories/596